Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.33B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.22B |
| 3 |
JPMorgan Chase
JPM
|
+$761M |
| 4 |
Bank of America
BAC
|
+$427M |
| 5 |
Alibaba
BABA
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.49B |
| 2 |
Apple
AAPL
|
+$1.26B |
| 3 |
Microsoft
MSFT
|
+$685M |
| 4 |
Tesla
TSLA
|
+$478M |
| 5 |
Netflix
NFLX
|
+$297M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.84% |
| 2 | Technology | 1.62% |
| 3 | Communication Services | 1.38% |
| 4 | Financials | 1.25% |
| 5 | Consumer Discretionary | 1.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
CALL
Invesco CurrencyShares Euro Currency Trust
FXE
$360M
| $13.7M | ﹤0.01% |
128,900
-88,800
| -41% | -$9.24M |
|
1777
PUT
Charles River Laboratories
CRL
$14.2B
| $13.7M | ﹤0.01% |
78,300
+58,500
| +295% | +$9.34M |
|
|
CLR
1778
PUT
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $13.6M | ﹤0.01% |
777,100
+173,600
| +29% | +$2.44M |
|
1779
CALL
CEL-SCI Corp
CVM
$28.1M
| $13.6M | ﹤0.01% |
30,367
+23,334
| +332% | +$9.58M |
|
1780
PUT
HP
HPQ
$26.7B
| $13.6M | ﹤0.01% |
779,500
-843,200
| -52% | -$13.4M |
|
1781
State Street Utilities Select Sector SPDR ETF
XLU
$22.2B
| $13.6M | ﹤0.01% |
481,400
-1,570,936
| -77% | -$45.3M |
|
|
WRK
1782
CALL
DELISTED
WestRock Company
WRK
| $13.6M | ﹤0.01% |
480,400
-131,900
| -22% | -$3.75M |
|
1783
KLA
KLAC
$240B
| $13.6M | ﹤0.01% |
697,990
+19,830
| +3% | +$339K |
|
1784
CALL
Nutrien
NTR
$34.9B
| $13.6M | ﹤0.01% |
422,800
+125,200
| +42% | +$4.36M |
|
1785
Constellation Brands
STZ
$22.4B
| $13.6M | ﹤0.01% |
77,561
+8,054
| +12% | +$1.34M |
|
1786
CALL
Sunrun
RUN
$2.18B
| $13.6M | ﹤0.01% |
687,100
+146,400
| +27% | +$2.24M |
|
1787
PUT
ManpowerGroup
MAN
$2.89B
| $13.5M | ﹤0.01% |
197,000
+186,600
| +1,794% | +$12.7M |
|
1788
PUT
SS&C Technologies
SSNC
$19.6B
| $13.5M | ﹤0.01% |
239,800
+162,600
| +211% | +$8.86M |
|
1789
CALL
NovoCure
NVCR
$2.09B
| $13.5M | ﹤0.01% |
228,200
-115,800
| -34% | -$7.62M |
|
1790
CRISPR Therapeutics
CRSP
$5.74B
| $13.5M | ﹤0.01% |
184,042
-19,955
| -10% | -$1.17M |
|
|
CCXI
1791
DELISTED
ChemoCentryx, Inc.
CCXI
| $13.5M | ﹤0.01% |
234,468
+21,849
| +10% | +$1.19M |
|
1792
CALL
Ameriprise Financial
AMP
$49.1B
| $13.5M | ﹤0.01% |
89,900
-15,100
| -14% | -$1.94M |
|
1793
PUT
Jazz Pharmaceuticals
JAZZ
$16.3B
| $13.5M | ﹤0.01% |
122,000
+100,900
| +478% | +$11.2M |
|
1794
Descartes Systems
DSGX
$6.91B
| $13.5M | ﹤0.01% |
254,274
-48,797
| -16% | -$2.17M |
|
1795
Vanguard S&P 500 ETF
VOO
$1.03T
| $13.4M | ﹤0.01% |
47,424
+20,200
| +74% | +$5.44M |
|
1796
TransUnion
TRU
$16.2B
| $13.4M | ﹤0.01% |
154,370
-106,960
| -41% | -$8.54M |
|
1797
PUT
International Flavors & Fragrances
IFF
$22.2B
| $13.4M | ﹤0.01% |
109,700
+56,400
| +106% | +$7.13M |
|
1798
PUT
Invesco CurrencyShares British Pound Sterling Trust
FXB
$65.3M
| $13.4M | ﹤0.01% |
111,900
-132,600
| -54% | -$15.9M |
|
1799
Schwab International Small-Cap Equity ETF
SCHC
$5.8B
| $13.4M | ﹤0.01% |
+454,030
| New | +$12.5M |
|
1800
CALL
iShares Russell 1000 Value ETF
IWD
$84B
| $13.4M | ﹤0.01% |
119,100
+13,700
| +13% | +$1.51M |
|
Similar funds
Jeff Yass's Q2 2020 Portfolio in Review
As of Q2 2020, Jeff Yass held 11,586 positions worth $415B, up 32% from $314B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Jeff Yass's Q2 2020 filing shows 1,443 new, 4,471 increased, 4,026 reduced and 1,558 closed positions. Its largest new stake was VelocityShares 3x Long Natural Gas ETN linked to the S&P GSCI Natural Gas Index ER due February 9, 2: 1,220,649 shares worth $12.4M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 92% a quarter earlier, followed by Technology and Communication Services.
- Jeff Yass's largest Q2 2020 buy was VelocityShares 3x Long Natural Gas ETN linked to the S&P GSCI Natural Gas Index ER due February 9, 2: 1,220,649 shares worth $12.4M.
- Jeff Yass added most to Invesco QQQ Trust in Q2 2020, an estimated $2.33B increase.
- Jeff Yass's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.49B.
- Jeff Yass fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, selling an estimated $119M.
- Jeff Yass's ten largest holdings make up 30% of its $415B portfolio in Q2 2020.
- Jeff Yass opened 1,443 new positions and closed 1,558 in Q2 2020.
- Jeff Yass's portfolio value rose 32% quarter-over-quarter to $415B.
Based on Susquehanna International Group's 13F filing for Q2 2020, filed 14 Aug 2020.